Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice.

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

Unwarranted variation of coronary stent choice in The Netherlands. Neth Heart J (2016) 0.83

Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry. J Am Heart Assoc (2014) 0.83

Drug eluting balloons for de novo coronary lesions - a systematic review and meta-analysis. BMC Med (2013) 0.79

Clinical utility of platinum chromium bare-metal stents in coronary heart disease. Med Devices (Auckl) (2015) 0.78

How drug-eluting stents illustrate our health system's flawed relationship with technology: comment on "use of drug-eluting stents as a function of predicted benefit". Arch Intern Med (2012) 0.77

Safety and efficacy of a novel iopromide-based paclitaxel-eluting balloon following bare metal stent implantation in rabbit aorta abdominalis. Biomed Mater Eng (2015) 0.76

Stent choice and the hidden consequences of cost savings. Nat Rev Cardiol (2012) 0.76

Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease. World J Cardiol (2015) 0.75

Predicting target vessel revascularization in older patients undergoing percutaneous coronary intervention in the drug-eluting stent era. Am Heart J (2014) 0.75

Stratification of coronary artery disease patients for revascularization procedure based on estimating adverse effects. BMC Med Inform Decis Mak (2015) 0.75

Understanding physician-level barriers to the use of individualized risk estimates in percutaneous coronary intervention. Am Heart J (2016) 0.75

Laminin Receptor-Avid Nanotherapeutic EGCg-AuNPs as a Potential Alternative Therapeutic Approach to Prevent Restenosis. Int J Mol Sci (2016) 0.75

The association of chronic kidney disease with the use of renin-angiotensin system inhibitors after acute myocardial infarction. Am Heart J (2015) 0.75

Neoatherosclerosis in Very Late Stenosis of Bare Metal Stent by Optical Coherence Tomography. Case Rep Cardiol (2016) 0.75

Systematic overuse of healthcare services: a conceptual model. Appl Health Econ Health Policy (2015) 0.75

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74

Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17

Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74

Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57

Screening for serious mental illness in the general population. Arch Gen Psychiatry (2003) 15.75

A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25

Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA (2013) 12.37

Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19

Telemonitoring in patients with heart failure. N Engl J Med (2010) 10.82

Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54

Clinical end points in coronary stent trials: a case for standardized definitions. Circulation (2007) 10.31

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14

Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med (2015) 9.58

Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91

Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science (2005) 8.20

Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med (2012) 8.19

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11

Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med (2013) 8.08

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA (2009) 7.78

ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol (2006) 7.77

Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med (2008) 7.75

Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med (2006) 7.54

ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol (2009) 7.36

Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA (2007) 7.12

Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01

Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA (2012) 6.96

Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation (2005) 6.89

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol (2011) 6.35

Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation (2008) 6.30

An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes (2008) 6.00

Percutaneous repair or surgery for mitral regurgitation. N Engl J Med (2011) 5.78

Trends in survival after in-hospital cardiac arrest. N Engl J Med (2012) 5.67

Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes (2009) 5.66

Pay for performance in commercial HMOs. N Engl J Med (2006) 5.52

Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49

An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation (2006) 5.35

Medication adherence: its importance in cardiovascular outcomes. Circulation (2009) 5.30

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res (2009) 5.20

National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA (2011) 5.16

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation (2011) 5.09

Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA (2006) 5.06

Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol (2007) 4.99

Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation (2011) 4.95

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol (2012) 4.77

Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation (2007) 4.74

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA (2003) 4.74

Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation (2007) 4.58

An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation (2006) 4.52

Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med (2006) 4.44

The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 4.39

Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA (2010) 4.36

Appropriateness of percutaneous coronary intervention. JAMA (2011) 4.33

Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med (2015) 4.27

Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA (2009) 4.24

Physician clinical performance assessment: prospects and barriers. JAMA (2003) 4.16

Serum potassium levels and mortality in acute myocardial infarction. JAMA (2012) 4.09

Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA (2008) 4.06

A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat Med (2008) 3.98

Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail (2009) 3.95

Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ (2005) 3.94

Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina). J Am Coll Cardiol (2013) 3.90

Long-term outcomes in elderly survivors of in-hospital cardiac arrest. N Engl J Med (2013) 3.85

Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA (2007) 3.79

Behavioral health insurance parity for federal employees. N Engl J Med (2006) 3.77

Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg (2006) 3.77

Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med (2007) 3.71

Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med (2008) 3.68

Variability in the measurement of hospital-wide mortality rates. N Engl J Med (2010) 3.65

Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation (2012) 3.61

Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation (2006) 3.45

The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg (2009) 3.45

Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J (2008) 3.40

Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Endorsed by the American College of Cardiology Foundation. Circulation (2005) 3.38

Automated external defibrillators and survival after in-hospital cardiac arrest. JAMA (2010) 3.36

Recent declines in hospitalizations for acute myocardial infarction for Medicare fee-for-service beneficiaries: progress and continuing challenges. Circulation (2010) 3.32

An administrative claims measure suitable for profiling hospital performance based on 30-day all-cause readmission rates among patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes (2011) 3.31

Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease. Circulation (2013) 3.30

Hospital-wide code rates and mortality before and after implementation of a rapid response team. JAMA (2008) 3.30

Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med (2008) 3.29

Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol (2012) 3.29

Hospital variation in time to defibrillation after in-hospital cardiac arrest. Arch Intern Med (2009) 3.27

Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J (2005) 3.26

Improvements in speed-based gait classifications are meaningful. Stroke (2007) 3.26